Pattern of cardiac sympathetic denervation in idiopathic parkinson disease studied with11C hydroxyephedrine PET

Radiology

Volumn 265, Issue 1, 2012, Pages 240-247

  Wong, Ka Kit ^a,c   Raffel, David M ^a   Koeppe, Robert A ^a   Frey, Kirk A ^a   Bohnen, Nicolaas I ^a,b,c   Gilman, Sid ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYEPHEDRINE; CARBON 11;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIAC SYMPATHETIC DENERVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE WALL; HUMAN; HUMAN TISSUE; IDIOPATHIC PARKINSON DISEASE; INFORMED CONSENT; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SEX DIFFERENCE; SYMPATHETIC INNERVATION;

AGED; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CONTRAST MEDIA; EPHEDRINE; FEMALE; HEART; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 84866606715     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112723     Document Type: Article

References (44)

1. Goldstein DS. Imaging of the autonomic nervous system: focus on cardiac sympathetic innervation. Semin Neurol 2003;23(4):423-433. (Pubitemid 38437513)
2. Akincioglu C, Unlu M, Tunc T. Cardiac innervation and clinical correlates in idiopathic Parkinson's disease. Nucl Med Commun 2003;24(3):267-271.
3. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lücking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53(5):1020-1025. (Pubitemid 29442118)
4. Druschky A, Hilz MJ, Platsch G, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000;175(1):3-12. (Pubitemid 30227477)
5. Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin IJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997;336(10):696- 702. (Pubitemid 27102684)
6. Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 2002;58(8):1247-1255. (Pubitemid 34411870)
7. Hamada K, Hirayama M, Watanabe H, et al. Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74(4):423-426. (Pubitemid 36379361)
8. Kim JS, Lee KS, Song IU, et al. Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. J Neurol Sci 2008;270(1-2):122-126.
9. Kim JS, Lee PH, Lee KS, et al. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism. Mov Disord 2006;21(11):1990-1994.
10. Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease. J Neurol Sci 2008;264(1-2):22-26. (Pubitemid 350193242)
11. Lee PH, Yeo SH, Kim HJ, Youm HY. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006;21(11):1975-1977. (Pubitemid 44848949)
12. Matsui H, Udaka F, Oda M, Kubori T, Nishinaka K, Kameyama M. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy. Auton Neurosci 2005;119(1):56-60. (Pubitemid 40704699)
13. Orimo S, Amino T, Itoh Y, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (Berl) 2005;109(6):583-588. (Pubitemid 40974147)
14. Orimo S, Oka T, Miura H, et al. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002;73(6):776-777. (Pubitemid 35448873)
15. Saiki S, Hirose G, Sakai K, et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 2004;220(1-2):105-111. (Pubitemid 38622107)
16. Satoh A, Serita T, Seto M, et al. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999;40(3):371-375. (Pubitemid 29120107)
17. Spiegel J, Hellwig D, Farmakis G, et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord 2007;22(7):1004-1008. (Pubitemid 46999298)
18. Takatsu H, Nagashima K, Murase M, et al. Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. JAMA 2000;284(1):44-45. (Pubitemid 30445658)
19. Takatsu H, Nishida H, Matsuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000;41(1):71-77. (Pubitemid 30046686)
20. Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000;27(5):566-573. (Pubitemid 30262623)
21. Yoshita M, Hayashi M, Hirai S. Iodine 123-labeled meta- iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy [in Japanese]. Rinsho Shinkeigaku 1997;37(6):476-482. (Pubitemid 27459112)
22. 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006;66(12):1850-1854.
23. Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 2005;15(1):29-34. (Pubitemid 40224064)
24. Orimo S, Kanazawa T, Nakamura A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol (Berl) 2007;113(1):81-86. (Pubitemid 44782932)
25. Orimo S, Uchihara T, Nakamura A, et al. Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008;131(Pt 3):642-650. (Pubitemid 351294710)
26. Berding G, Schrader CH, Peschel T, et al. [N-methyl 11C]meta- hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 2003;30(1):127-131. (Pubitemid 36692903)
27. Raffel DM, Koeppe RA, Little R, et al. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. J Nucl Med 2006;47(11):1769-1777. (Pubitemid 47544999)
28. Bengel FM, Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 2004;11(5):603-616. (Pubitemid 39341805)
29. Münch G, Ziegler S, Nguyen N, Hartmann F, Watzlowik P, Schwaiger M. Scintigraphic evaluation of cardiac autonomic innervation. J Nucl Cardiol 1996;3(3):265-277. (Pubitemid 26248485)
30. Schwaiger M, Kalff V, Rosenspire K, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990;82(2):457-464. (Pubitemid 20257824)
31. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56(1):33-39. (Pubitemid 29046907)
32. Bohnen NI, Albin RL, Koeppe RA, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 2006;26(9):1198-1212. (Pubitemid 44268182)
33. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010;33(2):434-441.
34. Rosenspire KC, Haka MS, Van Dort ME, et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med 1990;31(8):1328-1334. (Pubitemid 20245929)
35. Raffel DM, Corbett JR, del Rosario RB, et al. Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons. J Nucl Med 1996;37(12):1923-1931. (Pubitemid 26428355)
36. Jewett DM, Kilbourn MR, Lee LC. A simple synthesis of [11C]dihydrotetrabenazine (DTBZ). Nucl Med Biol 1997;24(2):197-199.
37. 11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. J Cereb Blood Flow Metab 1997;17(9):919-931.
38. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16(5):834-840. (Pubitemid 26292051)
39. Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. J Cereb Blood Flow Metab 1999;19(12):1376-1384. (Pubitemid 30013629)
40. 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. J Nucl Med 2006;47(7):1099-1101.
41. Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO III. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 2000;133(5):338-347.
42. Li ST, Dendi R, Holmes C, Goldstein DS. Progressive loss of cardiac sympathetic innervation in Parkinson's disease. Ann Neurol 2002;52(2):220-223. (Pubitemid 34810603)
43. Janes RD, Brandys JC, Hopkins DA, Johnstone DE, Murphy DA, Armour JA. Anatomy of human extrinsic cardiac nerves and ganglia. Am J Cardiol 1986;57(4):299-309. (Pubitemid 16140402)
44. Janes RD, Johnstone DE, Brandys JC, Armour JA. Functional and anatomical variability of canine cardiac sympathetic efferent pathways: implications for regional denervation of the left ventricle. Can J Physiol Pharmacol 1986;64(7):958-969. (Pubitemid 16025713)